PDE4 allosteric inhibitors (Tetra Therapeutics)

N/A

Report date: 2025/03/20 15:32:32
NME

Base Information

Drug NamePDE4 allosteric inhibitors (Tetra Therapeutics)
Drug Alias NamePDE4 allosteric inhibitors (Tetra Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsCognitive DysfunctionBrain Injuries, Traumatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTetra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTetra Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A